Genomictree gets approval for publication in international journal on technology to co-deliver two tumor suppressor factors
Predicted impact: Low
Journal publication approval for a drug-delivery technology is routine and small versus company size.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.